\'In Nature\'s infinite book of secrecy, a little I can read.\'

*Antony and Cleopatra*\[Act I, Scene 2\], William Shakespeare

Pathological mutations occurring within the extended consensus sequences of exon-intron splice junctions account for \~10 per cent of all inherited lesions logged in The *Human Gene Mutation Database*(HGMD^®^; <http://www.hgmd.org>)\[[@B1]\] and are frequently encountered in mutation screening studies \[[@B2]\]. Mutations residing in other intronic locations (including the canonical branch-point sequence,\[[@B3]\] 5^\'^-YURAY-3^\'^), however, may often go undetected unless patient RNA can be analysed and the mutations in question induce aberrant splicing (eg exon skipping or cryptic splice site utilisation) that is readily distinguishable qualitatively or quantitatively from normal (and/or normal alternative) splicing. Indeed, introns probably represent a substantially larger mutational target than has hitherto been appreciated, on account of their containing a multiplicity of functional elements, including intron splice enhancers and silencers that regulate alternative splicing,\[[@B4],[@B5]\]*trans*-splicing elements \[[@B6]\] and other regulatory elements, some of which may be deeply embedded within very large introns \[[@B7]\].

In addition to pathological mutations *sensu stricto*, introns also harbour functional polymorphisms that can influence the expression of the genes that host them. Some of these intronic variants may also confer susceptibility to disease or otherwise modulate the genotype-phenotype relationship. For the reasons discussed above, it is very likely that such variants will have been seriously under-ascertained to date. Although most of these variants are single nucleotide polymorphisms (SNPs), others may be of the insertion/deletion type \[[@B8]\]. With the advent of genome-wide association studies (GWAS), an increasing number of potentially functional intronic variants are being identified \[[@B9]\]. In the majority of cases, however, it is unclear whether such variants are of direct functional significance, as opposed to simply being in linkage disequilibrium with another (as yet unidentified) functional SNP in the vicinity \[[@B10]\]. Even when GWAS studies deem a newly identified intronic polymorphism to be \'functional\', it should be appreciated that such a term may often be ascribed solely on the basis of an observed association between a specific allele and a plasma protein level, enzymatic activity or a clinical/laboratory phenotype \-- even although in reality such associations cannot readily distinguish a bona fide functional SNP from a linkage disequilibrium effect.

As has been noted with pathological mutations, the vast majority of known functional intronic polymorphisms are located within the extended consensus sequences of exon-intron splice junctions \[[@B2]\]. Some intronic polymorphic variants do not occur within the splice junctions, however, but nevertheless still act so as to change the splicing phenotype as a consequence of their being located within an intron splice enhancer or branchpoint site, or by activating a cryptic splice site \[[@B11],[@B12]\]. This is, from a biological point of view, a more interesting category of intronic SNP to study, since the mechanisms by which these variants exert their effects on the splicing phenotype are often unclear and may be quite subtle. In the pages of this issue, Millar *et al*.\[[@B13]\] report that a SNP, buried deep within intron 4 of the human growth hormone (*GH1*) gene, is of direct functional significance by virtue of its influence on the expression of this gene. This polymorphism therefore joins the ranks of the hitherto relatively small number of human intronic SNPs located outwith exon-intron splice junctions that have been shown by various methods of *in vitro*characterisation to be of direct functional significance. Table [1](#T1){ref-type="table"} lists some of the best characterised examples of such functional SNPs, most of which are located at least \~30 base pairs (bp) from the nearest splice site. These SNPs have been shown to influence either the transcriptional activity or the splicing efficiency of their host genes, or instead to alter the expression of alternative transcripts.

###### 

Selected examples of *in vitro*characterised human functional intronic polymorphisms located more than \~30 bp from the nearest splice site

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene       Disease/phenotype                                                        Chromosomal location   Polymorphism, intronic location and dbSNP number   Consequences for gene expression or mRNA splicing                                                                                             Reference
  ---------- ------------------------------------------------------------------------ ---------------------- -------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------
  *AGTR2*    Predisposition to congenital anomalies of the kidney and urinary tract   Xq22-q23               IVS1, AS, A \> G, -29\                             SNP occurs within branchpoint motif and alters splicing efficiency                                                                            Nishimura *et al.*(1999)^a^
                                                                                                             (rs1403543)                                                                                                                                                                                      

  *BANK1*    Susceptibility to systemic lupus erythematosus                           4q23                   IVS1, AS, T \> C, -43\                             SNP occurs within branchpoint motif and risk allele alters expression of alternative transcripts                                              Kozyrev *et al.*(2008)^b^
                                                                                                             (rs17266594)                                                                                                                                                                                     

  *CD244*    Susceptibility to rheumatoid arthritis                                   1q23.1                 IVS3, AS, T \> C, -164\                            Risk allele associated with increased transcriptional activity                                                                                Suzuki *et al.*(2008)^c^
                                                                                                             (rs6682654)                                                                                                                                                                                      

  *CD244*    Susceptibility to rheumatoid arthritis                                   1q23.1                 IVS5, DS, G \> A, +526 (rs3766379)                 Risk allele associated with increased transcriptional activity                                                                                Suzuki *et al.*(2008)^c^

  *COL1A1*   Reduced bone density/osteoporosis                                        17q21.33               IVS1, AS, G \> T, -440\                            SNP occurs within Sp1-binding site; risk allele alters Sp1 binding and transcriptional activity                                               Mann *et al.*(2001)^d^
                                                                                                             (rs1800012)                                                                                                                                                                                      

  *CXCR3*    Variation in immune cell response to chemokine-cytokine signals          Xq13                   IVS1, DS, G \> A, +234\                            Risk allele associated with reduced *CXCR3*gene expression                                                                                    Choi *et al.*(2008)^e^
                                                                                                             (rs2280964)                                                                                                                                                                                      

  *CYP2D6*   Intermediate metaboliser (reduced expression of CYP2D6)                  22q13.1                IVS6, DS, G \> A, +39\                             Increased level (7.3-fold) of non-functional splice variant transcript lacking exon 6 and reduced level (2.9-fold) of functional transcript   Toscano *et al*.\
                                                                                                             (rs28371725)                                                                                                                                                                                     (2006)^f^

  *DRD2*     Reduced DRD2 expression                                                  11q22-q23              IVS1, DS, A \> G, +3850\                           Risk allele associated with increased binding of transcriptional repressor (Freud-1) leading to reduced *DRD2*expression                      Rogaeva\
                                                                                                             (rs2734836)                                                                                                                                                                                      *et al.*(2007)^g^

  *DRD2*     Reduced DRD2 expression                                                  11q23                  IVS6, AS, C \> A, -83\                             Risk allele alters expression of alternative transcripts                                                                                      Zhang *et al*.\
                                                                                                             (rs 1076560)                                                                                                                                                                                     (2007)^h^

  *F2*       Elevated prothrombin level/thrombosis                                    11p11-q12              IVS13, AS, A \> G, -59                             Risk allele influences splicing efficiency                                                                                                    von Ahsen & Oellerich (2004)^i^

  *FGFR2*    Susceptibility to breast cancer                                          10q26                  IVS2, DS, T \> C,+ 12912\                          Risk allele alters binding affinity for transcription factors Oct-1/Runx2, leading to increased *FGFR2*expression                             Meyer *et al*.\
                                                                                                             (rs2981578)                                                                                                                                                                                      (2008)^j^

  *FOXP3*    Susceptibility to psoriasis                                              Xp11.23                IVS1, DS, A \> C, +2882\                           Risk allele causes loss of binding of E47 and c-Myb, leading to reduced FOXP3 transcription                                                   Shen *et al*.\
                                                                                                             (rs3761548)                                                                                                                                                                                      (2010)^k^

  *GFPT1*    Reduced GFPT1 expression                                                 2p13                   IVS1, DS, T \> C, +36\                             SNP occurs within GC box and risk allele decreases transcriptional activity                                                                   Kunika *et al*.\
                                                                                                             (rs6720415)                                                                                                                                                                                      (2006)\[[@B1]\]

  *GSK3B*    Risk of Parkinson\'s disease                                             3q13.3                 IVS5, AS, T \> C, -157\                            Risk allele associated with increased level of *GSK3B*transcripts lacking exons 9 and 11                                                      Kwok *et al*.\
                                                                                                             (rs6438552)                                                                                                                                                                                      (2005)^m^

  *IRF4*     Risk of childhood acute lymphoblastic leukaemia in males                 6p25-p23               IVS4, DS, C \> T, +386\                            Risk allele increases IRF4 promoter activity/expression                                                                                       Do *et al*.\
                                                                                                             (rs12203592)                                                                                                                                                                                     (2010)^n^

  *LTA*      Susceptibility to myocardial infarction                                  6p21.3                 IVS1, AS, G \> A, -198\                            Risk allele associated with increased transcriptional activity                                                                                Ozaki *et al*.\
                                                                                                             (rs909253)                                                                                                                                                                                       (2002)^o^

  *NLRP3*    Susceptibility to food-induced anaphylaxis                               1q44                   IVS7, AS, C \> T, -202\                            Risk allele increases enhancer activity by 20%                                                                                                Hitomi *et al*.\
                                                                                                             (rs4612666)                                                                                                                                                                                      (2009)^p^

  *SCG3*     Association with obesity                                                 15q21                  IVS1, DS, G \> A, +190\                            Risk allele alters transcriptional activity                                                                                                   Tanabe *et al*.\
                                                                                                             (rs16964476)                                                                                                                                                                                     (2007)^q^

  *TH*       Risk of essential tension                                                11p15.5                IVS12, DS, T \> C, +127\                           Risk allele associated with increased transcriptional activity                                                                                Wang *et al*.\
                                                                                                             (rs2070762)                                                                                                                                                                                      (2008)^r^

  *USF1*     Association with familial combined hyperlipidaemia                       1q22-q23               IVS7, AS, G \> A, -100\                            SNP alleles exhibit differential binding to nuclear proteins.\                                                                                Naukkarinen *et al.*(2005)^s^\
                                                                                                             (rs2073658)                                        USF1-regulated genes are differentially regulated, depending on the identity of the rs2073658 allele                                          Naukkarinen *et al.*(2009)^t^
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations**: AS, acceptor splice site; DRD2, dopamine D2 receptor; DS, donor splice site; IVS, intron (number) Nucleotide numbering relative to specified splice site.

rs numbers are provided courtesy of dbSNP <http://www.ncbi.nlm.nih.gov/projects/SNP/>. For the sake of simplicity, only SNPs have been included in Table 1 (thus, for example, functional intronic microsatellite polymorphisms would require a separate treatment).
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How should we go about increasing the number of identified functional intronic polymorphisms? One approach would be to employ exon-tiling microarrays to perform genome-wide scans to identify intronic SNPs responsible for inter-individual differences in the splicing phenotype \[[@B11],[@B14],[@B15]\]. Since currently available bioinformatics tools are inadequate to the task of predicting splicing consequences,\[[@B14]\] however, all SNPs identified in this way would have to be further validated using mini-gene constructs to determine the resulting splicing phenotype \[[@B14]\]. One feature that might prove helpful in identifying intronic SNPs is that such variants are often located within gene regions that are characterised by a reduced level of genetic variation \[[@B16]\].

Precisely because we invariably adopt a gene-centric approach to screening introns for functional polymorphisms, we should be wary of the existence of overlapping genes, a not infrequent occurrence in our complex genome. Thus, for example, the functional SNP rs4988235, located 13.9 kilobases upstream of the lactase (*LCT*) gene and associated with adult-type hypolactasia, actually resides deep within intron 13 of the minichromosome maintenance complex component 6 (*MCM6*) gene \[[@B17]-[@B19]\]. In addition, since disease-associated intronic SNPs that play a role in long-range gene regulation have also recently been identified,\[[@B20],[@B21]\] we should be aware that some SNPs may influence the expression of remote genes at distance, rather than the expression of those genes which actually host them. These caveats notwithstanding, new techniques such as chromosome conformational capture \[[@B22]\] and chromatin immunoprecipitation followed by deep sequencing (ChIP-seq)\[[@B23]\] promise greatly to increase the number of functional intronic polymorphisms identified, thereby potentially pinpointing the locations of a whole new lexicon of intron-located regulatory elements, which will increase our understanding of intron structure and function.
